stockrowColgate-Palmolive Company
CL Consumer Defensive Household & Personal Products
Colgate-Palmolive Company’s revenue for fiscal 2025 (year ended December 2025) was $20.4 billion, up 1.40% from fiscal 2024.
- Revenue
- +4.64%
- EPS
- +7.42%
- Free cash flow
- −6.24%
- Total debt
- −8.35%
Quarter to September 2026, against a year earlier
Follow CL
Alert me
Colgate-Palmolive Company (CL) EBITDA
Colgate-Palmolive Company's EBITDA for fiscal 2025 was $4.9B, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $4.7B. Over the past ten years it has ranged from $3.2B (fiscal 2015) to $4.9B (fiscal 2024); the current reading is higher than 91% of that period. Colgate-Palmolive Company ranks 3rd of 28 Household & Personal Products companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $4.9B | (0.37%) |
| FY2024 | $4.9B | 7.08% |
| FY2023 | $4.6B | 9.43% |
| FY2022 | $4.2B | (6.73%) |
| FY2021 | $4.5B | 0.79% |
| FY2020 | $4.4B | 8.62% |
| FY2019 | $4.1B | (3.14%) |
| FY2018 | $4.2B | 0.55% |
| FY2017 | $4.2B | (4.91%) |
| FY2016 | $4.4B | 35.82% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Sep 2026 | $1.2B | 6.49% |
| Jun 2026 | $1.2B | 4.55% |
| Mar 2026 | $1.1B | (5.33%) |
| Dec 2025 | $1.2B | (2.79%) |
| 43 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| UL Unilever PLC compare | $25.1B |
| PG Procter & Gamble Company (The) compare | $23.0B |
| CL Colgate-Palmolive Company | $4.7B |
| KMB Kimberly-Clark Corporation compare | $3.2B |
| EL The Estee Lauder Companies Inc. compare | $1.8B |
| CHD Church & Dwight Co., Inc. compare | $1.4B |
| CLX The Clorox Company compare | $1.3B |
| IPAR Interparfums, Inc. compare | $292.6M |
| ELF e.l.f. Beauty compare | $221.4M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on CL
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement